Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: Results from a clinical series
Số trang: 11
Loại file: pdf
Dung lượng: 399.09 KB
Lượt xem: 11
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Stage shift is widely considered a major determinant of the survival benefit conferred by breast cancer screening. However, factors and mechanisms underlying such a prognostic advantage need further clarification. We sought to compare the molecular characteristics of screen detected vs. symptomatic breast cancers and assess whether differences in tumour biology might translate into survival benefit.
Nội dung trích xuất từ tài liệu:
Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: Results from a clinical series
Nội dung trích xuất từ tài liệu:
Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: Results from a clinical series
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Breast cancer Mode of detection Molecular categories Survival outcomesTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
13 trang 38 0 0